Tricida, Inc.

OTCPK:TCDA.Q Rapporto sulle azioni

Cap. di mercato: US$580.0

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Tricida Gestione

Gestione criteri di controllo 3/4

Tricida's CEO is Gerrit Klaerner, appointed in Aug 2013, they has a tenure of 9.83 years. Their total yearly compensation is $4.68M , comprised of 12.8% salary and 87.2% bonuses, including company stock and options. They directly owns 0.68% of the company’s shares, worth $3.93. The average tenure of the management team and the board of directors is 4 years and 9.5 years respectively.

Informazioni chiave

Gerrit Klaerner

Amministratore delegato

US$4.7m

Compenso totale

Percentuale dello stipendio del CEO12.8%
Mandato del CEO9.8yrs
Proprietà del CEO0.7%
Durata media del management4yrs
Durata media del Consiglio di amministrazione9.5yrs

Aggiornamenti recenti sulla gestione

Recent updates

Tricida enters $125M debt facility

Oct 19

Tricida: Important Binary Event Coming Up

Sep 21

Calculating The Intrinsic Value Of Tricida, Inc. (NASDAQ:TCDA)

Sep 14
Calculating The Intrinsic Value Of Tricida, Inc. (NASDAQ:TCDA)

Insider Buying: The Tricida, Inc. (NASDAQ:TCDA) CFO & Executive VP Just Bought 6.5% More Shares

Dec 14
Insider Buying: The Tricida, Inc. (NASDAQ:TCDA) CFO & Executive VP Just Bought 6.5% More Shares

Tricida revises VALOR-CKD trial protocol, updates patent protection, shares down 14%

Dec 09

Tricida's Veverimer CRL And Regulatory Updates: An Analysis

Nov 17

Tricida slumps 46% on FDA feedback on veverimer proposal; launches cost-cutting initiatives

Oct 29

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Gerrit Klaerner rispetto agli utili di Tricida?
DataCompenso totaleStipendioGuadagni aziendali
Sep 30 2022n/an/a

-US$134m

Jun 30 2022n/an/a

-US$148m

Mar 31 2022n/an/a

-US$153m

Dec 31 2021US$5mUS$600k

-US$177m

Sep 30 2021n/an/a

-US$181m

Jun 30 2021n/an/a

-US$219m

Mar 31 2021n/an/a

-US$244m

Dec 31 2020US$9mUS$598k

-US$265m

Sep 30 2020n/an/a

-US$268m

Jun 30 2020n/an/a

-US$235m

Mar 31 2020n/an/a

-US$213m

Dec 31 2019US$10mUS$584k

-US$177m

Sep 30 2019n/an/a

-US$146m

Jun 30 2019n/an/a

-US$131m

Mar 31 2019n/an/a

-US$120m

Dec 31 2018US$1mUS$503k

-US$103m

Sep 30 2018n/an/a

-US$96m

Jun 30 2018n/an/a

-US$77m

Mar 31 2018n/an/a

-US$60m

Dec 31 2017US$821kUS$425k

-US$41m

Compensazione vs Mercato: Gerrit's total compensation ($USD4.68M) is above average for companies of similar size in the US market ($USD747.42K).

Compensazione vs guadagni: Gerrit's compensation has been consistent with company performance over the past year.

AMMINISTRATORE DELEGATO

Gerrit Klaerner (51 yo)

9.8yrs

Mandato

US$4,676,490

Compensazione

Dr. Gerrit Klaerner, Ph.D. Founded Tricida, Inc.and has been its Chief Executive Officer and President since August 2013 and has been its an Executive Director since July 2013. Dr. Klaerner was the Founder...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Gerrit Klaerner
Founder9.8yrsUS$4.68m0.68%
$ 3.9
Geoffrey Parker
COO, CFO & Executive VP6.2yrsUS$2.51m0.72%
$ 4.2
Robert McKague
Executive VP3.3yrsUS$2.43m0.031%
$ 0.2
Dawn Parsell
Executive Vice President of Clinical Development4.8yrsUS$2.77m0.0060%
$ 0.03
Annie Yoshiyama
VP of Finance & Chief Accounting Officer2.5yrsNessun datoNessun dato
Jackie Cossmon
Vice President of Investor Relations & Communicationsno dataNessun datoNessun dato
Edward Hejlek
Executive Vice President of Intellectual Property3.3yrsUS$2.10mNessun dato

4.0yrs

Durata media

58yo

Età media

Gestione esperta: TCDA.Q's management team is considered experienced (4 years average tenure).

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Gerrit Klaerner
Founder9.9yrsUS$4.68m0.68%
$ 3.9
Kathryn Falberg
Independent Non-Employee Director5.1yrsUS$329.00k0.074%
$ 0.4
Klaus Veitinger
Independent Chairman of the Board9.3yrsUS$379.00k0.20%
$ 1.1
David Hirsch
Independent Non-Employee Director6.9yrsUS$326.50k0.019%
$ 0.1
Robert Alpern
Independent Non-Employee Director and Member of Scientific & Clinical Advisory Board9.7yrsUS$314.00kNessun dato
John Fordtran
Member of Scientific & Clinical Advisory Boardno dataNessun datoNessun dato
David Bushinsky
Member of Scientific & Clinical Advisory Boardno dataNessun datoNessun dato
Craig Hawker
Member of Scientific & Clinical Advisory Boardno dataNessun datoNessun dato
Sandra Coufal
Independent Non-Employee Director and Member of Scientific & Clinical Advisory Board9.9yrsUS$316.50k0.15%
$ 0.9
Navdeep Tangri
Member of Scientific & Clinical Advisory Boardno dataNessun datoNessun dato
Thomas Hostetter
Member of Scientific & Clinical Advisory Boardno dataNessun datoNessun dato
Bertram Pitt
Member of Scientific and Clinical Advisory Boardno dataNessun datoNessun dato

9.5yrs

Durata media

60yo

Età media

Consiglio di amministrazione esperto: TCDA.Q's board of directors are considered experienced (9.5 years average tenure).